Publications by authors named "Jacques Troncy"

Claim this Profile
H
Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial.
John Porter, Donald K Bowden, Marina Economou, Jacques Troncy, Arnold Ganser

Anemia· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule.
Olfa Derbel, Giovanna Cannas, Quoc-Hung Le, Mohamed Elhamri, Youcef Chelghoum, Jacques Troncy

Hematology· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.
Natacha Heutte, Henning H Flechtner, Nicolas Mounier, Wilhelmina A M Mellink, Jacobus H Meerwaldt, Jacques Troncy

Lancet Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arsenic: a beneficial therapeutic poison - a historical overview.
Xavier Thomas, Jacques Troncy

Adler Mus Bull· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rationale and use of hypomethylation agents in adult acute myeloid leukemia.
Xavier Thomas, Youcef Chelghoum, Fiorenza Barraco, Jacques Troncy

Expert Opin Drug Discov· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial.
Thierry Facon, Jean Yves Mary, Cyrille Hulin, Lotfi Benboubker, Michel Attal, Jacques Troncy

Lancet· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study.
Jean-Luc Harousseau, Michel Attal, Xavier Leleu, Jacques Troncy, Brigitte Pegourie

Haematologica· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous hematopoietic stem cell transplantation for adults with acute myeloid leukemia in complete remission: the Edouard Herriot Hospital experience.
Anne-Sophie Michallet, Youcef Chelghoum, Anne Thiebaut, Quoc-Hung Le, Thomas Prebet, Jacques Troncy

Hematology· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy.
Thierry Facon, Jean-Yves Mary, Brigitte Pégourie, Michel Attal, Marc Renaud, Jacques Troncy

Blood· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of gemcitabine in relapsed or refractory multiple myeloma.
Xavier Leleu, Jacques Troncy, Fadela Bouafia, Mauricette Michallet, Thierry Facon

Haematologica· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Imatinib mesylate-induced acute cytolytic hepatitis].
Pierre Rocca, Saïd El Jastimi, Jacques Troncy, Jean-Yves Scoazec, Alexandra Boucher

Gastroenterol Clin Biol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis